Skip to main content

Table 2 Comparisons of baseline characteristics and echocardiographic data between patients with and without adverse outcomes

From: Significant functional tricuspid regurgitation portends poor outcomes in patients with atrial fibrillation and preserved left ventricular ejection fraction

Variables Adverse outcomes
(n = 57)
No adverse outcomes
(n = 243)
P-value
Baseline characteristics
 Age (year) 71.8 ± 10.4 68.1 ± 10.9 0.019
 Female gender 42 (73.7) 108 (44.4) <  0.001
 Non-paroxysmal AF 42 (73.7) 154 (63.4) 0.192
 CHA2DS2-VASc score 4.3 ± 1.9 3.0 ± 1.6 <  0.001
 Hypertension 49 (86.0) 186 (76.9) 0.132
 Dyslipidemia 26 (45.6) 127 (52.3) 0.366
 Diabetes mellitus 25 (43.9) 80 (32.9) 0.119
 History of stroke 27 (48.2) 61 (25.1) 0.001
 History of heart failure 15 (26.3) 30 (12.3) 0.008
 Diuretics 25 (43.9) 33 (13.6) <  0.001
Echocardiographic data
 Significant FTR 29 (50.9) 36 (14.8) < 0.001
 LVEF (%) 65.6 ± 7.5 65.2 ± 6.0 0.635
 LVDdi (mm/m2) 25.7 ± 5.9 25.7 ± 3.7 0.994
 LVSdi (mm/m2) 16.5 ± 3.6 16.5 ± 4.9 0.876
 LAV index (ml/m2) 54.0 ± 16.2 47.9 ± 15.3 0.008
 TAPSE (mm) 18.6 ± 2.9 19.7 ± 3.1 0.027
 S’TV (cm/s) 13.5 ± 13.4 11.5 ± 2.2 0.073
 Impaired RV systolic function 15 (26.3) 29 (11.9) 0.006
 RAP (mmHg) 8.6 ± 3.9 7.4 ± 3.2 0.015
 Mean PAP (mmHg) 27.2 ± 8.5 22.8 ± 6.5 < 0.001
 PASP (mmHg) 42.9 ± 13.3 37.1 ± 10.8 0.001
 Pulmonary hypertension 28 (49.1) 64 (26.3) 0.001
  1. Data are expressed as number (percentage) and mean ± standard deviation
  2. Abbreviations: AF atrial fibrillation, FTR functional tricuspid regurgitation, LAV left atrial volume, LVDdi left ventricular diastolic dimension index, LVEF left ventricular ejection fraction, LVSdi left ventricular systolic dimension index, PAP pulmonary artery pressure, PASP pulmonary artery systolic pressure, RAP right atrial pressure, RV right ventricular, S’TV peak systolic myocardial velocity of lateral tricuspid annulus, TAPSE tricuspid annular plane systolic excursion